Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men

AIDS

Volumn 19, Issue 13, 2005, Pages 1407-1414

  Palefsky, Joel M ^a,b   Holly, Elizabeth A ^a   Efirdc, Jimmy T ^a   Da Costa, Maria ^a   Jay, Naomi ^b   Berry, J Michael ^b   Darragh, Teresa M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anal cancer; Anal dysplasia; Anal intraepithelial neoplasia; Highly active antiretroviral therapy; HIV; Human papillomavirus

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANUS TUMOR; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CELL COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM TUMOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RECTUM BIOPSY; SEXUAL BEHAVIOR; VIRUS IDENTIFICATION; VIRUS LOAD; WART VIRUS;

EID: 29144526124     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000181012.62385.4a     Document Type: Article

References (32)

1. Daling JR, Weiss NS, Hislop TG, Maden C, Coates RJ, Sherman KJ, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987; 317:973-977.
2. Holly EA, Whittemore AS, Aston DA, Ahn DK, Nickoloff BJ, Kristiansen JJ. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 1989; 81:1726-1731.
3. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998; 351:1833-1839.
4. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500-1510.
5. Cress RD, Holly EA. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev Med 2003; 36:555-560.
6. Qualters JR, Lee NC, Smith RA, Aubert RE. Breast and cervical cancer surveillance, United States, 1973-1987. MMWR CDC Surveill Summ 1992; 41:1-7.
7. Palefsky JM, Holly EA, Ralston ML, Arthur SP, Jay N, Berry JM, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:320-326.
8. Critchlow CW, Surawicz CM, Holmes KK, Kuypers J, Daling JR, Hawes SE, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995; 9:1255-1262.
9. Palefsky JM, Holly EA, Hogeboom CJ, Ralston ML, DaCosta MM, Botts R, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:314-319.
10. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12:495-503.
11. Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, et al. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. JAMA 1999; 282:1633-1637.
12. Deayton JR, Wilson P, Sabin CA, Davey CC, Johnson MA, Emery VC, et al. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS 2000; 14:1163-1170.
13. Appleby P, Beral V, Newton R, Reeves G. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92:1823-1830.
14. Palefsky JM, Holly EA, Ralston ML, Da Costa MM, Bonner H, Jay N, et al. The effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immun Defic Syndr 2001; 28:422-428.
15. Jay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic correlates of anal squamous intraepithelial lesions. Dis Col Rectum 1997; 40:919-928.
16. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177:361-367.
17. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91:226-236.
18. Greenspan D, Canchola A, MacPhail L, Cheikh B, Greenspan J. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001; 357:1411-1412.
19. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine M. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 1998; 12: 1459-1464.
20. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001; 15:2157-2164.
21. Lillo F, Ferrari D, Veglia F, Uberti-Foppa C. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001; 184:547-551.
22. Heard I, Tassié J, Kazatchkine M, Orth G. Increased regression of CIN in HIV-seropositive women under HAART. AIDS 2002; 16:1799-1802.
23. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004; 9:13-22.
24. Piketty C, Darragh TM, Heard I, Da Costa M, Bruneval P, Kazatchkine MD, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31:96-99.
25. Rabkin CS. Association of non-acquired immunodeficiency syndrome-defining cancers with human immunodeficiency virus infection. J Natl Cancer Inst Monogr 1998; 23:23-25.
26. Critchlow CW, Surawicz CM, Holmes KK, Kuypers J, Daling JR, Hawes SE, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995; 9:1255-1262.
27. Palefsky JM, Holly EA. Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003; 31:41-46.
28. Robinson WR, Hamilton CA, Michaels SH, Kissinger P. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol 2001; 184:538-543.
29. Chin-Hong PV, Vittinghoff E, Buchbinder S, Cohen D, Colfax G, Da Costa M, et al. Age-related prevalence of anal human papillomavirus infection among sexually active men who have sex with men. J Infec Dis 2004; 190:2070-2076.
30. Cranston RD, Darragh TM, Holly EA, Jay N, Berry JM, Costa M, et al. Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr 2004; 36:915-920.
31. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical-effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281:1822-1829.
32. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. The clinical benefits and cost-effectiveness of screening for anal squamous intraepithelial lesions and anal squamous cell cancer in homosexual and bisexual men. Am J Med 2000; 108:634-641.